Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells

Yaoxue Xuebao

Volumn 48, Issue 12, 2013, Pages 1829-1835

  Wen, Zhen ^a   Li, Gang ^b   Lin, Dong Hai ^a   Wang, Jun Teng ^a   Qin, Li Fang ^a   Guo, Gui Ping ^a  

^a Pharmacy School   (Japan)

^b YANTAI UNIVERSITY   (China)

Author keywords

Caco 2 HT29 MTX co cultured cell; Furanodiene; Mucus; PLGA nanoparticle; Transport

Indexed keywords

BIOCOMPATIBLE COATED MATERIAL; CHITOSAN; DRUG CARRIER; FURAN DERIVATIVE; FURANODIENE; FUSED HETEROCYCLIC RINGS; LACTIC ACID; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTEIN ZO1;

CACO 2 CELL LINE; CHEMISTRY; COCULTURE; HT 29 CELL LINE; HUMAN; METABOLISM; PARTICLE SIZE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; COCULTURE TECHNIQUES; DRUG CARRIERS; FURANS; HETEROCYCLIC COMPOUNDS, 2-RING; HT29 CELLS; HUMANS; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84894343654     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jin Y, Song YP, Zhu X, et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport [J], Biomaterials, 2012, 33: 1573 -1582.
2. Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres [J], Science, 1994, 263: 1600-1603. (Pubitemid 24128361)
3. Vila A, Sánchez A, Tobío M, et al. Design of biodegradable particles for protein delivery [J], J Control Release, 2002, 78: 15-24. (Pubitemid 34081849)
4. Kim D, El-Shall H, Dennis D, et al. Interaction of PLGA nanoparticles with human blood constituents [J], Colloids Surf B Biointerf, 2005,40: 83-91. (Pubitemid 40092448)
5. Tang BC, Dawson M, Lai SK, et al. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier [J], Proc Nati Acad Sci USA, 2009, 106: 19268-19273.
6. Cu Y, Booth CJ, Saltzman WM. In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery [J], J Control Release, 2011, 156: 258-264.
7. Shah P, Jogani V, Bagchi T, et al. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption [J], Biotechnol Prog, 2006, 22: 186-198. (Pubitemid 43221545)
8. Hilgendorf C, Spahn-Langguth H, Regârdh CG et al. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport [J]. J Pharm Sci, 2000, 89: 63 -75.
9. Xie XX, Wang JT, Qin LF, et al. Preparation and properties of mPEG-PLGA nanoparticles and evaluation of their in vitro antiadhesive ability [J]. Chin Hosp Pharm J 2012,32: 1727-1731.
10. Chen XM, Elisia I, Kitts DD. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design [J]. J Pharmacol Toxicol Methods, 2010, 61: 334 342
11. Pontier C, Pachot J, Botham R, et al. HT29-MTX and Caco-2/ TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer [J]. J Pharm Sci, 2001, 90: 1608-1619. (Pubitemid 32979755)
12. Li G Lin DH, Xie XX, et al. Uptake and transport of furanodiene in Caco-2 cell monolayers: a comparison study between furanodiene and furanodiene loaded PLGA nanoparticles [J]. Chin J Nat Med, 2013, 11:49-55.
13. Sha XY, Fang XL. Effect of self-microemulsifying system on cell tight junctions [J]. Acta Pharm Sin 2006,41:30-35.
14. Klmnvilkar K, Donovan MD, Flanagan DR. Drug transfer through mucus [J]. Adv Drug Deliv Rev, 2001,48: 173 193
15. Wang JT, Lin DH, Qin LF, et al. Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa [J]. Acta Pharm Sin, 2013,48: 752-758.
16. Leng W, Zheng Y, Li SP, et al. Study on absorption mechanisms of zedoary turmeric oil by Caco-2 cell model [J], Chin Pharm J 2007,42: 1228-1232. (Pubitemid 47492449)